BackgroundAndrogenetic alopecia is a common dermatological condition affecting both genders.ObjectiveTo evaluate the tendency towards development of psychosexual disorders according to the clinical stages of androgenetic alopecia.MethodsA cross-sectional study was conducted including 353 patients of both sexes on different clinical stages of hair loss, and the patients were enquired about self-perception, self-esteem, sexual experiences, anxiety and depression states. Hair loss was classified by standardized hair loss scales, and psychological effects were assessed with questionnaires. Results were compared to p<0.05.ResultsNegative effects on each psychological parameter of androgenetic alopecia in females were higher than in males. While overall comparisons according to hair loss stages for each parameter were significant in males, only sexual experiences, anxiety and depression values were significant in females. Sexual experiences and depression values were higher in Ludwig 3 than in 1&2, while anxiety was higher in Ludwig 3 than 1. Self-perception values in Norwood 2&2A were higher than 3A, 3V, 4 and 4A, while self-esteem values in 2A were higher than 3&4. Sexual experiences values in 2&2A were lower than 3, 3A, 3V, 4 and 4A, while 3&3A were lower than 4&4A. Depression was lower in 2A than 3, 3A, and 3V, and lower in 2A than 4A. Anxiety was lower in 2A than in 4&4A.Study limitationsRelatively small number of patients, who were from a single center.ConclusionsIn the management of androgenetic alopecia, it should be considered that patients may need psychological support according to the clinical stages, because of increased tendency to develop psychosexual disorders.
Borderline personality disorder (BPD) is a chronic psychiatric disorder characterized by pervasive affective instability, self-image disturbances, impulsivity, marked suicidality, and unstable interpersonal relationships as the core dimensions of psychopathology underlying the disorder. Across a wide range of situations, BPD causes significant impairments. Patients with BPD suffer considerable morbidity and mortality compared with other populations. Although BPD is more widely studied than any other personality disorder, it is not understood sufficiently. This paper briefly reviews the recent evidence on the prevalence, etiology, comorbidity, and treatment approaches of borderline personality disorder (BPD) by examining published studies, and aims to offer a more coherent framework for the understanding and management of borderline personality disorder.
Impulsivity is a key feature of numerous psychiatric disorders. This paper reviews the recent evidences on the impulsivity in elderly, relationship between impulsivity and borderline personality disorder (BPD) with attention-deficit/hyperactivity disorder (ADHD), impulsivity with anxiety and mood disorders, and the psychopharmacological approaches to impulsivity evaluating previously published studies. A literature review of the theoretical bases of the relationship between psychiatric disorders and impulsivity is presented. Measurements of impulsivity and neurobiological hypothesis are defined. Treatment approaches are discussed. Previous researches have shown significantly higher levels of impulsivity among patients with BPD, ADHD, anxiety, and mood disorders. In addition, older adults could be more impulsive than younger adults. But the nature of this relationship remains unclear. This is probably due to the fact that there is much overlap between them. Impulsivity is a risk for suicidality and influences pathogenesis, course, clinical severity of many psychiatric disorders. Pharmacological interventions for treating impulsivity should be incorporated into treatment plans for these disorders. Identifying the role of pharmacological interventions in modulating the development of trait impulsivity may prevent progression to psychiatric disorders and associated adverse consequences. ARTICLE HISTORY
Objective: Previous studies reported that there were significant associations between Attention-deficit/hyperactivity disorder (ADHD) and borderline personality disorder (BPD). In this study, we aimed to examine complex relationship between childhood trauma, impulsivity, dissociative symptoms, and the impact of ADHD on this relationship in a sample of patients with BPD. Methods: Our samples consisted of 165 BPD patients (128 female, 37 male) and 165 healthy subjects (128 female, 37 male) of similar age and gender. We administered the semistructured socio-demographic data form, Adult Self-Report Scale, Barratt Impulsivity Scale (BIS-11), Childhood Trauma Questionnaire, and Dissociation Questionnaire. Results: The BPD group exhibited greater ADHD symptoms, impulsivity, childhood trauma, and dissociation compared to the healthy group. A statistically significant association was found between adult ADHD symptoms and impulsivity, childhood trauma, and dissociation scores. The logistic regression analysis indicated that gender, attentional and motor impulsiveness were the predictors of ADHD in BPD patients. Among these, gender and emotional neglect were the predictors of dissociation in BPD patients. Conclusion: Our results suggested a strong association between impulsivity, childhood trauma, dissociation, and ADHD symptoms in patients with BPD. The findings are mostly consistent with the literature. Clinicians should be aware of these symptoms among these populations to develop treatment strategies.
OBJECTIVES: In this present study, we aimed to examine the relationship between impulsivity and attention-deficit/hyperactivity symptoms in female patients with borderline personality disorder (BPD) and compare these symptoms with a healthy group. METHODS: The sample of this study was composed of randomly selected 90 female patients diagnosed with BPD according to Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition (DSM-5) criteria and not receiving any medical treatment during the past six months since presented to the Bagcilar Training and Research Hospital and randomly selected 90 healthy controls who were free of any psychiatric disorders. Semi-structured sociodemographic data form, Adult ADHD Self-Report Scale (ASRS-v1.1), and Barratt Impulsiveness Scale (BIS-11) were administered. RESULTS: Total BIS scores were statistically significantly correlated with total ASRS (r = .557, p < .001) and its two subscales: Inattention (r = .593, p < .001) and Hyperactivity/Impulsivity (r = .399, p < .001). The results of Chi-square test revealed a statistically significant difference in terms of being diagnosed with attention-deficit/hyperactivity disorder (ADHD) or not between patient and healthy group (χ 2 = 46.667, df = 1, p = .000). Furthermore, there was a statistically significant difference between the patients and the healthy controls in terms of total BIS-11 [t(178) = 10.444, p = .000] and total ASRS [t(178) = 9.697, p = .000]. The results of hierarchical multiple regression revealed that Motor subscale scores were significantly predictive of ASRS scores [R 2 = .337, F(6,82) = 5.960, p = .00]. CONCLUSIONS: In this present study, patients with BPD had higher rates of comorbid ADHD and impulsivity scores than healthy controls. ASRS scores and BIS scores were positively correlated, and motor subscale scores were significantly predictive of ASRS scores.
OBJECTIVE: Smith and Burger developed the Structured Inventory of Malingered Symptomatology (SIMS) in 1997 as a self-report measure for malingering of psychiatric symptoms. The SIMS consists of 75 dichotomous (True-False) items that form into five subscales Psychosis (P), Neurologic Impairment (NI), Affective Disorder (AF), Amnestic Disorders (AM), Low Intelligence (LI); each subscale containing 15 items. In this study, we aimed to examine the reliability, validity, and factor structure of the SIMS in a Turkish forensic psychiatry sample. METHODS: A sample of 103 forensic patients (9 female, 94 male), aged 18-75, undergoing an inpatient forensic evaluations for competency to stand trial (CST) were recruited from a large forensic hospital in Turkey. The study protocol was approved by the local Ethics Committee. Sociodemographic information of the participants was collected and the SIMS, Miller Forensic Assessment of Symptoms Test (M-FAST), the Scales of Psychological Well-being, 36-Item Short Form Survey (SF-36), Beck Depression Inventory (BDI) and Beck Anxiety Inventory (BAI) were administered. All statistical analyses were performed by using SPSS version 23.0 for Windows. RESULTS: The Cronbach's alpha coefficients for the Turkish SIMS were ranging from 0.32 to 0.88. The lowest alpha coefficient was observed for the Low Intelligence (0.32). For the whole scale, Cronbach's alpha coefficient was found to be 0.93. The test-retest (at after 1 week) correlation coefficients for Psychosis (P), Neurologic Impairment (NI), Affective Disorder (AF), Amnestic Disorders (AM), Low Intelligence (LI), and whole scale were found to be 0.
Schizophrenia typically has age of onset during late adolescence or early adulthood; yet, several patients manifest symptoms for the first time in middle or old age. These patients with late (older than 40 years) or very-late-onset schizophrenia (older than 60 years) have similar characteristics to those with early-onset schizophrenia regarding psychopathology, family history, cognitive deficits, non-specific brain imaging abnormalities, course of illness and treatment response. During the 20’th century, schizophrenic symptoms that onset after 40's are defined as “late onset schizophrenia”, “late parafreni”, “very late onset schizophrenia” or late psychoses. In those days neither ICD-10 nor DSM-IV had no separate codeable diagnoses for late-onset schizophrenia and there is no age restriction. Our patient was 70 years old woman, who was living with her sister came to psychiatric outpatient clinic with the symptoms of paranoid persecutory delusion and delusion of reference, diagnosed as a “paranoid schizophrenia” according to DSM- IV criterias. She administered paliperidone and neuroimaging and laboratory tests, neuropsychological assessments were done in the inpatient unit. A new classification would be more appropriate for such late onset schizophrenia cases which differentiate by the clinical features etiology, treatment and prognosis in DSM-V.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.